--- title: "SANA Side Effects: Complete 2026 Safety Guide" url: https://www.bodyhackguide.co/side-effects/sana description: "SANA side effects, contraindications, severity tiers, and how to minimize adverse reactions. Evidence-based safety guide updated 2026." lang: en --- Skip to content Compare notes on r/BodyHackGuide (https://reddit.com/r/bodyhackguide) Compare notes with other researchers. Join r/BodyHackGuide (https://reddit.com/r/bodyhackguide) 2026 Safety Guide # SANA Side Effects Complete SANA safety profile: reported side effects from published research, contraindications, severity tiers, and how to minimize adverse reactions through proper dosing and vendor selection. ## Reported SANA side effects Phase 1 trial (41 volunteers, up to 15 days of dosing) All human safety data come from one phase 1 trial in 41 volunteers, with at most 15 days of dosing (PMID: 40527924). Two participants had adverse events judged definitively related to SANA: reversible damage to the kidney tubules, seen as protein and glucose in the urine, after the highest single dose of 800 mg (PMID: 40527924). The safety review committee ended the single-dose part before the last participant in the 800 mg cohort was dosed; it judged that the no-observed-adverse-effect level had been determined (PMID: 40527924). No adverse events judged definitively drug-related occurred in the 15-day multiple-dose part of the SANA trial, and the most frequent possibly drug-related events were headache and soft stools (PMID: 40527924). No severe adverse events were recorded, liver function was normal in all participants after 15 days, and no moderate or severe gastrointestinal adverse effects were reported (PMID: 40527924). One participant in the lowest multiple-dose cohort was withdrawn because of mild proteinuria, which was judged unrelated to SANA and probably due to kidney disease missed at screening (PMID: 40527924). Participants reported no change in appetite or satiety on a questionnaire, and one participant in the highest-dose group had higher fasting glucose despite lower weight and insulin (PMID: 40527924). Animal data Eight weeks of SANA at 400 mg/kg a day in normal mice showed no signs of kidney or liver toxicity (PMID: 40527924). In mice lacking the mitochondrial creatine kinase CKMT1, SANA at room temperature was followed by a roughly 50 percent increase in mortality within a week, while no normal mice died, and housing at thermoneutrality prevented the deaths; the authors suggest SANA commits mice to creatine-dependent heat production at the expense of other heat-producing pathways (PMID: 40527924). In normal mice, SANA did not impair shivering, skeletal muscle creatine kinase or mitochondrial function, exercise capacity, or heart mitochondrial respiration and function, although it raised muscle creatine levels (PMID: 40527924). What is not known No human data on SANA beyond 15 days, in pregnancy, in children or with other medicines were found (PMID: 40527924). ## When to continue, reduce, or stop SANA Mild: continue protocol Transient mild symptoms (slight GI upset, minor injection-site reaction, brief fatigue) typically resolve within 3-7 days as physiology adjusts. Continue at current dose; monitor weekly. Moderate: reduce dose Persistent mild symptoms past two weeks, or new symptoms like sustained mood changes, sleep disruption, or appetite shifts. Reduce dose by 25-50% and reassess at the end of the next 2-week window. Severe: discontinue + seek care Any signal of allergic response (rash, swelling, breathing difficulty), unexplained chest discomfort, severe injection-site reaction with infection signs, or vision changes. Discontinue immediately and consult a licensed practitioner. ## SANA contraindications SANA is an experimental compound with no approved label, so no official contraindications exist. The cautions below come from the phase 1 and animal findings and are reported as the sources state them. Kidney function warrants caution: the only adverse events judged definitively related to SANA in the phase 1 trial were reversible kidney tubule damage after a single 800 mg dose, and a participant with probable undetected kidney disease developed proteinuria during the trial (PMID: 40527924). Defects in creatine metabolism are a concern from animal work: in mice lacking the creatine kinase CKMT1, SANA at room temperature was followed by deaths that did not occur in normal mice (PMID: 40527924). SANA is built on the salicylate scaffold, the parent compound of aspirin (PMID: 40527924), and no study has tested SANA in people with aspirin or salicylate sensitivity. Pregnancy, children and long-term use fall outside the data: the SANA trial enrolled adults aged 18 to 60 for at most 15 days of dosing, and no data in pregnancy or in children were found (PMID: 40527924). ## Why vendor quality drives SANA side-effect frequency Research-compound communities consistently report that adverse-event frequency tracks with source quality. Three reasons: (1) impurity profiles vary by lab (residual synthesis byproducts can trigger reactions); (2) mislabeled mass means actual dose can be 50-150% of stated dose; (3) reconstitution-grade water and capping methodology affect long-term storage stability. COA-verified vendors with published HPLC data minimize all three failure modes. Check a vendor's COA record and Trust Score before you buy. Full SANA profile Mechanism, dosing, half-life, peer-reviewed studies. https://www.bodyhackguide.co/compound/sana SANA protocol Three-tier dosing protocol with cycle structure. https://www.bodyhackguide.co/protocol/sana Alternatives If side-effect profile rules out SANA for you, similar compounds. https://www.bodyhackguide.co/alternatives-to/sana ## SANA side effects FAQ ### What are the most common SANA side effects? Phase 1 trial (41 volunteers, up to 15 days of dosing) All human safety data come from one phase 1 trial in 41 volunteers, with at most 15 days of dosing (PMID: 40527924). Two participants had adverse events judged definitively related to SANA: reversible damage to the kidney tubules, seen as protein and glucose in the urine, after the highest single dose of 800 mg (PMID: 40527924). The safety rev ### Are there severe side effects to watch for with SANA? Severe reactions are rare in published research but can occur. Watch for: allergic-type symptoms (rash, swelling, breathing difficulty), unexplained chest discomfort, infection signs at injection sites, vision changes, or severe persistent mood/sleep disruption. Any of these warrants immediate discontinuation and consultation with a licensed practitioner. The Severity Tiers section above triages mild → moderate → severe response patterns. ### Does SANA have contraindications? SANA is an experimental compound with no approved label, so no official contraindications exist. The cautions below come from the phase 1 and animal findings and are reported as the sources state them. Kidney function warrants caution: the only adverse events judged definitively related to SANA in the phase 1 trial were reversible kidney tubule damage after a single 800 mg dose, and a participant ### How can I minimize SANA side effects? Three biggest levers: (1) Start at the Beginner-tier dose for 2-3 weeks before escalating, which gives time to detect adverse signals at minimum effective dose. (2) Source from COA-verified vendors only: impurity profiles and mislabeled compounds drive a disproportionate share of reported side effects in research-compound communities. (3) Maintain adequate cycle off-time when applicable: receptor-saturating compounds benefit from 4-6 week breaks. The vendor section below lists the cheapest in-stock SANA sources we track, each linked to its Trust Score (COA verification is 30% of the score). **Research-use disclaimer.** All safety information on this page summarizes published research literature and community-reported reactions. It is not medical advice and not authorization for human consumption. Always consult a licensed practitioner before any compound enters a clinical context. Compounds linked from this page are sold for research-use only. **Affiliate disclosure.** See our affiliate disclosure (https://www.bodyhackguide.co/affiliate-disclosure). Free 2026 Peptide Cheat Sheet (PDF) 38 compounds and blends: vial sizes, BAC water volumes, dosing ranges and bloodwork markers. Download Free (https://www.bodyhackguide.co/guides/peptide-cheat-sheet-download) BodyHackGuide (https://www.bodyhackguide.co/) Your biohacking research hub: compound pricing, brain health protocols, dosing tools, and vendor reviews. support@bodyhackguide.co Join our Discord: https://discord.gg/Mhq5UdRYBA r/BodyHackGuide on Reddit: https://reddit.com/r/BodyHackGuide **Affiliate Disclosure:** We rank every vendor on the same public, reproducible methodology (https://www.bodyhackguide.co/vendors/methodology). Full details in our affiliate disclosure (https://www.bodyhackguide.co/affiliate-disclosure). **Research Disclaimer:** All compounds listed are for laboratory and research purposes only. Not for human consumption. This site does not sell or ship any products. Always consult a qualified healthcare professional and comply with local regulations. © 2026 BodyHackGuide. All rights reserved. - Terms: https://www.bodyhackguide.co/terms - Privacy: https://www.bodyhackguide.co/privacy ## Structured data ```json [ { "@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.bodyhackguide.co/" }, { "@type": "ListItem", "position": 2, "name": "Compare", "item": "https://www.bodyhackguide.co/compare" }, { "@type": "ListItem", "position": 3, "name": "SANA Side Effects" } ] }, { "@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.bodyhackguide.co" }, { "@type": "ListItem", "position": 2, "name": "Compare", "item": "https://www.bodyhackguide.co/compare" }, { "@type": "ListItem", "position": 3, "name": "SANA Side Effects", "item": "https://www.bodyhackguide.co/side-effects/sana" } ] }, { "@context": "https://schema.org", "@type": "Drug", "name": "SANA", "description": "Research compound. Safety profile, side effects, and contraindications summary.", "availableStrength": { "@type": "DrugStrength", "strengthValue": "" }, "contraindication": "SANA is an experimental compound with no approved label, so no official contraindications exist. The cautions below come from the phase 1 and animal findings and are reported as the sources state them. Kidney function warrants caution: the only adverse events judged definitively related to SANA in t" }, { "@context": "https://schema.org", "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "What are the most common SANA side effects?", "acceptedAnswer": { "@type": "Answer", "text": "Phase 1 trial (41 volunteers, up to 15 days of dosing) All human safety data come from one phase 1 trial in 41 volunteers, with at most 15 days of dosing (PMID: 40527924). Two participants had adverse events judged definitively related to SANA: reversible damage to the kidney tubules, seen as protein and glucose in the urine, after the highest single dose of 800 mg (PMID: 40527924). The safety rev" } }, { "@type": "Question", "name": "Are there severe side effects to watch for with SANA?", "acceptedAnswer": { "@type": "Answer", "text": "Severe reactions are rare in published research but can occur. Watch for: allergic-type symptoms (rash, swelling, breathing difficulty), unexplained chest discomfort, infection signs at injection sites, vision changes, or severe persistent mood/sleep disruption. Any of these warrants immediate discontinuation and consultation with a licensed practitioner. The Severity Tiers section above triages mild → moderate → severe response patterns." } }, { "@type": "Question", "name": "Does SANA have contraindications?", "acceptedAnswer": { "@type": "Answer", "text": "SANA is an experimental compound with no approved label, so no official contraindications exist. The cautions below come from the phase 1 and animal findings and are reported as the sources state them. Kidney function warrants caution: the only adverse events judged definitively related to SANA in the phase 1 trial were reversible kidney tubule damage after a single 800 mg dose, and a participant " } }, { "@type": "Question", "name": "How can I minimize SANA side effects?", "acceptedAnswer": { "@type": "Answer", "text": "Three biggest levers: (1) Start at the Beginner-tier dose for 2-3 weeks before escalating, which gives time to detect adverse signals at minimum effective dose. (2) Source from COA-verified vendors only: impurity profiles and mislabeled compounds drive a disproportionate share of reported side effects in research-compound communities. (3) Maintain adequate cycle off-time when applicable: receptor-saturating compounds benefit from 4-6 week breaks. The vendor section below lists the cheapest in-stock SANA sources we track, each linked to its Trust Score (COA verification is 30% of the score)." } } ] } ] ```